Truist Financial Corp Decreases Stake in Exponent, Inc. (NASDAQ:EXPO)

Truist Financial Corp reduced its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 8.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,636 shares of the business services provider’s stock after selling 6,333 shares during the period. Truist Financial Corp’s holdings in Exponent were worth $6,383,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Conestoga Capital Advisors LLC grew its stake in Exponent by 1.6% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock valued at $323,535,000 after acquiring an additional 43,257 shares during the last quarter. State Street Corp grew its stake in Exponent by 0.7% in the 3rd quarter. State Street Corp now owns 1,840,313 shares of the business services provider’s stock valued at $212,151,000 after acquiring an additional 13,644 shares during the last quarter. Geneva Capital Management LLC grew its stake in Exponent by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after acquiring an additional 27,339 shares during the last quarter. Geode Capital Management LLC grew its stake in Exponent by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after acquiring an additional 69,099 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after acquiring an additional 245,086 shares during the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Exponent Trading Down 1.1 %

Shares of NASDAQ EXPO opened at $84.52 on Friday. The stock has a market cap of $4.29 billion, a price-to-earnings ratio of 39.87 and a beta of 0.71. Exponent, Inc. has a 52 week low of $75.81 and a 52 week high of $115.75. The company’s 50-day moving average price is $90.43 and its 200 day moving average price is $99.56.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the previous year, the business posted $0.41 EPS. As a group, research analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be paid a dividend of $0.30 per share. This is a boost from Exponent’s previous quarterly dividend of $0.28. This represents a $1.20 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Friday, March 7th. Exponent’s dividend payout ratio (DPR) is currently 52.83%.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.